Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours

Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumoursComplementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours, Published online: 22 February 2019; doi:10.1038/s41416-019-0389-6Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours

Source: British Journal of Cancer - February 22, 2019 Category: Cancer & Oncology Authors: C ésar Serrano Adri án Mariño-Enríquez Derrick L. Tao Julia Ketzer Grant Eilers Meijun Zhu Channing Yu Aristotle M. Mannan Brian P. Rubin George D. Demetri Chandrajit P. Raut Ajia Presnell Arin McKinley Michael C. Heinrich Jeffrey T. Czaplinski Ewa Si Source Type: research